Acquirer | Target | Price |
---|---|---|
Gilead Sciences, Inc. | Global partnership with Galapagos NV | $725 million |
AstraZeneca plc | Acerta Pharma B.V. | $4 billion |
AEA Investors LP | 1-800-Contacts, Inc. | N/A |
PharMerica Corporation | Alternacare Infusion Pharmacy | N/A |
TeamHealth Holdings, Inc. | Geriatric Essentials | N/A |